Anteris Technologies Global Corp.
AVRNasdaqHealthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | |
|---|---|---|
| Revenue | $1.9M | $2.7M |
| Operating income | −$93.9M | −$78.4M |
| Net income | −$94.1M | −$76.3M |
| Total assets | $23.0M | $80.7M |
| Total liabilities | $23.3M | $18.0M |
| Equity | −$93,000 | $62.8M |
| EPS (diluted) | $-2.55 | $-3.68 |
| Shares out. | 41.6M | 35.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −4908.2%
- Net margin
- −4921.3%
- Return on equity
- 101230.1%
- Return on assets
- −409.4%
- Return on capital (ROCE)
- −5781.7%
- Liabilities / assets
- 101.1%
- Debt / equity
- —
- Book value / share
- $-0.00
- Revenue growth (YoY)
- −29.2%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -81.59distress
- Accruals / assets
- −71.1%clean
- Beneish M-Score
- -6.28normal
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 5 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| L1 Capital Pty Ltd10% owner | Jan 22, 2026 | Buy | 5.0M | $5.75 |
| St Denis DavidOfficer — Chief Operating Officer | Dec 16, 2025 | Option exercise | 166,666 | — |
| Mcdonnell MatthewOfficer — Chief Financial Officer | Dec 16, 2025 | Option exercise | 27,777 | — |
| Paterson WayneOfficer — Chief Executive Officer | Dec 16, 2025 | Option exercise | 333,333 | — |
| Seaberg John DDirector | Dec 16, 2025 | Option exercise | 27,777 | — |
| Seaberg John DDirector | Mar 6, 2025 | Option exercise | 40,000 | $7.13 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 4.2M | 5.5 | +12.0% |
| Apr 30, 2026 | 3.7M | 5.2 | -9.5% |
| Apr 15, 2026 | 4.1M | 5.5 | -1.3% |
| Mar 31, 2026 | 4.2M | 3.3 | +73.5% |
| Mar 13, 2026 | 2.4M | 2.5 | +10.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreementMay 22, 2026
- Director / officer changeMay 13, 2026
- Results of operationsMay 13, 2026
- Terminated a material agreementApr 29, 2026
- Entered a material agreementApr 23, 2026
- Director / officer changeMar 3, 2026
- Results of operationsFeb 27, 2026
- Regulation FD disclosureJan 22, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 424B3May 26, 2026
- 8-KMay 22, 2026
- 424B5May 22, 2026
- 3FORM 3May 21, 2026
- 3FORM 3May 19, 2026
- 424B3May 18, 2026
- SCHEDULE 13G/AMay 15, 2026
- 8-KMay 13, 2026
- 8-KMay 13, 2026
- 10-QMay 12, 2026
- SCHEDULE 13G/AMay 4, 2026
- 424B3Apr 30, 2026
- 8-KApr 29, 2026
- SCHEDULE 13GApr 27, 2026
- 424B3Apr 27, 2026